Su Golder

13.5k total citations · 5 hit papers
152 papers, 8.1k citations indexed

About

Su Golder is a scholar working on Statistics, Probability and Uncertainty, General Health Professions and Economics and Econometrics. According to data from OpenAlex, Su Golder has authored 152 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Statistics, Probability and Uncertainty, 33 papers in General Health Professions and 29 papers in Economics and Econometrics. Recurrent topics in Su Golder's work include Meta-analysis and systematic reviews (42 papers), Health Systems, Economic Evaluations, Quality of Life (25 papers) and Pharmacovigilance and Adverse Drug Reactions (17 papers). Su Golder is often cited by papers focused on Meta-analysis and systematic reviews (42 papers), Health Systems, Economic Evaluations, Quality of Life (25 papers) and Pharmacovigilance and Adverse Drug Reactions (17 papers). Su Golder collaborates with scholars based in United Kingdom, United States and Canada. Su Golder's co-authors include Gilad Lotan, danah boyd, Yoon K. Loke, Mark Sculpher, Karl Claxton, Gill Norman, Kath Wright, Julie Glanville, Liliane Zorzela and Martin Bland and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Su Golder

144 papers receiving 7.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tweet, Tweet, Retweet: Conversational Aspects of Retweeting on Twitter

2010 1.4k citations Su Golder et al. profile →
Review of guidelines for good practice in decision-analytic modelling in health technology assessment

2004 528 citations Su Golder, R.P. Riemsma et al. Health Technology Assessment profile →
PRISMA harms checklist: improving harms reporting in systematic reviews

2016 391 citations Liliane Zorzela, Yoon K. Loke et al. BMJ profile →
Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis

2016 272 citations Su Golder et al. BMJ profile →
CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials

2023 111 citations Liliane Zorzela, Su Golder et al. BMJ profile →

Peers

Countries citing papers authored by Su Golder

Since Specialization

Citations

This map shows the geographic impact of Su Golder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Golder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Golder more than expected).

Fields of papers citing papers by Su Golder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Golder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Golder. The network helps show where Su Golder may publish in the future.

Co-authorship network of co-authors of Su Golder

This figure shows the co-authorship network connecting the top 25 collaborators of Su Golder. A scholar is included among the top collaborators of Su Golder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Golder. Su Golder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Barriers to and facilitators of women GPs’ careers: a systematic review 2025 ·BJGP Open ·Laura Jefferson, (unknown), Su Golder, (unknown), (unknown), Veronica Dale, Karen Bloor	0
2	Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysis 2025 ·Cochrane Database of Systematic Reviews ·Hanna Bergman, Nicholas Henschke, Ingrid Arévalo-Rodríguez, Brian S Buckley, Emma J. Crosbie, Jennifer Davies, Kerry Dwan, Su Golder, Yoon K. Loke, Katrin Probyn, Jennifer Petkovic, Gemma Villanueva, Jo Morrison	2
3	Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV-related disease and harms from vaccination 2025 ·Cochrane Database of Systematic Reviews ·Nicholas Henschke, Hanna Bergman, Brian S Buckley, Emma J. Crosbie, Kerry Dwan, Su Golder, Maria Kyrgiou, Yoon K. Loke, Heather M McIntosh, Katrin Probyn, Gemma Villanueva, Jo Morrison	3
4	AI as a Medical Device Adverse Event Reporting in Regulatory Databases: Protocol for a Systematic Review 2024 ·JMIR Research Protocols ·Aditya U. Kale, (unknown), (unknown), Henry David Jeffry Hogg, (unknown), Ben Glocker, Su Golder, Justin Waring, Xiaoxuan Liu, David Moore, Alastair K. Denniston	1
5	The commercial promotion of electronic cigarettes on social media and its influence on positive perceptions of vaping and vaping behaviours in Anglophone countries: A scoping review 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Su Golder	6
6	Development and Evaluation of a Framework for Identifying and Addressing Spin for Harms in Systematic Reviews of Interventions 2024 ·Annals of Internal Medicine ·Riaz Qureshı, (unknown), (unknown), Evan Mayo‐Wilson, Matthew J. Page, Victoria Cornelius, Roger Chou, Isabelle Boutron, Su Golder, Lisa Bero, Peter Doshi, Matt Vassar, Reint Meursinge Reynders, Tianjing Li	1
7	Patient-Reported Reasons for Antihypertensive Medication Change: A Quantitative Study Using Social Media 2023 ·Drug Safety ·(unknown), Su Golder, Karen O’Connor, Davy Weissenbacher, Robert Gross, Sean Hennessy, Graciela Gonzalez‐Hernandez	2
8	Psychological well-being of hospice staff: systematic review 2023 ·BMJ Supportive & Palliative Care ·(unknown), Lucy Ziegler, Bryony Beresford, Suzanne Mukherjee, Lorna Fraser, (unknown), Mark O’Neill, Su Golder, André Bedendo, Jo Taylor	9
9	Characterizing asset-based studies in public health: development of a framework 2023 ·Health Promotion International ·Jacqueline Martin‐Kerry, Jennifer McLean, (unknown), Antony Morgan, (unknown), Robert Walton, Su Golder, T. Allison, (unknown), Pia Wohland, Stephanie L. Prady	11
10	Best Practices on Big Data Analytics to Address Sex-Specific Biases in Our Understanding of the Etiology, Diagnosis, and Prognosis of Diseases 2022 ·PubMed ·Su Golder, Karen O’Connor, Yunwen Wang, Robin Stevens, Graciela Gonzalez‐Hernandez	5
11	THE COMMERCIAL PROMOTION OF ELECTRONIC CIGARETTES ON SOCIAL MEDIA AND ITS INFLUENCE ON VAPING INITIATION AND POSITIVE PERCEPTIONS OF VAPING IN ANGLOPHONE COUNTRIES: A SCOPING REVIEW PROTOCOL 2022 ·medRxiv ·(unknown), (unknown), Su Golder	1
12	The emperor has no clothes: a synthesis of findings from the Transformative Research on the Alcohol industry, Policy and Science research programme 2022 ·Addiction ·Jim McCambridge, (unknown), (unknown), (unknown), Su Golder, (unknown), Andrew Bartlett, Mary Madden	14
13	Assessment of Public-Private Partnership (PPP) models in health systems in least developed, low income and lower-middle-income countries and territories: A protocol for a Systematic Review 2022 ·Research Square ·(unknown), Zahidul Quayyum, (unknown), Deepa Barua, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Chukwuedozie K. Ajaero, Chinyere Okeke, Prince Agwu, (unknown), (unknown), Bassey Ebenso, Su Golder, Aishwarya Lakshmi Vidyasagaran, Helen Elsey	0
14	Understanding public opinion to the introduction of minimum unit pricing in Scotland: a qualitative study using Twitter 2019 ·BMJ Open ·Laurence Astill Wright, Su Golder, (unknown), Jim McCambridge	15
15	Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab 2018 ·Drug Safety ·Karen L. Smith, Su Golder, Abeed Sarker, Yoon K. Loke, Karen O’Connor, Graciela Gonzalez‐Hernandez	27
16	Quality of reporting in systematic reviews of adverse events: systematic review 2014 ·BMJ ·Liliane Zorzela, Su Golder, Yali Liu, Karen Pilkington, Lisa Hartling, Ari R. Joffe, Y. K. Loke, Sunita Vohra	157
17	Adverse Drug Reactions in Children—A Systematic Review 2012 ·PLoS ONE ·Rebecca MD Smyth, Elizabeth Gargon, Jamie J Kirkham, Lynne Cresswell, Su Golder, (unknown), (unknown), Paula Williamson	212
18	Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation 2008 ·Health Technology Assessment ·Mark Rodgers, Claire McKenna, Stephen Palmer, Duncan Chambers, (unknown), Su Golder, Chris Pepper, Derick Todd, Nerys Woolacott	57
19	A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents 2006 ·Health Technology Assessment ·Sarah King, Susan Griffin, Z. Hodges, Helen Weatherly, Christian Asseburg, Gerry Richardson, Su Golder, E. Taylor, Murray Drummond, R.P. Riemsma	133
20	A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers 2006 ·Health Technology Assessment ·E Andrea Nelson, Susan O’Meara, Dawn Craig, C Iglesias, Su Golder, Jane Dalton, K Claxton, Sally EM Bell-Syer, Edward B. Jude, Christopher G. Dowson, Roger Gadsby, Paul O’Hare, Janet T. Powell	171

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact